Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis.

Clinical chemistry and laboratory medicine - 1 Jan 2009

Kuna Andrea Tesija, Lamot Lovro, Miler Marijana, Harjacek Miroslav, Simundic Ana-Maria, Vrkic Nada

Abstract excerpt

BACKGROUND: The goal of the study was to assess the presence of antibodies to mutated citrullinated vimentin (anti-MCV) and cyclic citrullinated peptides (anti-CCP) in patients with juvenile idiopathic arthritis (JIA) compared with patients with other juvenile onset rheumatic diseases. METHODS: The study included 56 patients who fulfilled the International League of Associations for Rheumatology (ILAR)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies
Share to Arthritis, Juvenile

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Citrulline

Share to Enzyme-Linked Immunosorbent Assay

Share to Mutation

Share to Peptides, Cyclic

Share to Vimentin

Source

Identifiers

PMID: 19842993
DOI: 10.1515/CCLM.2009.288

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis.PMID 19842993Read ↗

Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis.Semantic proximity Read ↗

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy.Semantic proximity Read ↗

Antibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis.Semantic proximity Read ↗

Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis.Semantic proximity Read ↗

Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis.Semantic proximity Read ↗

Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.Semantic proximity Read ↗

Mutated citrullinated vimentin antibodies in rheumatoid arthritis.Semantic proximity Read ↗

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.Semantic proximity Read ↗

Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study.Semantic proximity Read ↗

Anti-Cyclic Citrullinated Peptide Antibodies in Patients with Juvenile Idiopathic ArthritisSemantic proximity Read ↗

Anti-mutated citrullinated vimentin antibody and rheumatoid factor (prevalence and association) in rheumatoid arthritis patients; Saudi and non-Saudi.Semantic proximity Read ↗

Higher levels of autoantibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis than in patients with psoriasis vulgaris.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.